SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-080835
Filing Date
2021-06-14
Accepted
2021-06-14 17:04:49
Documents
14
Period of Report
2021-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119609d1_8k.htm   iXBRL 8-K 27347
2 EXHIBIT 99.1 tm2119609d1_ex99-1.htm EX-99.1 27684
6 GRAPHIC tm2119609d1_ex99-1img001.jpg GRAPHIC 7928
  Complete submission text file 0001104659-21-080835.txt   246889

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20210614.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20210614_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20210614_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2119609d1_8k_htm.xml XML 3487
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 211015365
SIC: 2836 Biological Products, (No Diagnostic Substances)